锥形束CT引导在线自适应放疗用于前列腺SBRT的多中心回顾性研究
该多中心回顾性研究分析了74例接受5次分割CT引导在线自适应放疗(CTgART)的前列腺癌患者,评估该技术的可行性与剂量学改善。结果显示95%的分次采用了自适应计划,平均自适应计划时间为18.7±4.8分钟,85%的分次至少有一项剂量体积直方图(DVH)指标获得临床意义的改善。
要点
- 95%的分次选择了自适应计划,81%的患者全部5次分次均自适应。
- 平均自适应计划时间18.7±4.8分钟,各方向摆位误差均值<2 mm。
- 85%的分次至少有一项DVH指标获得临床意义改善。
核心结论
- 前列腺癌SBRT的CTgART可及时、可重复地实施,并显著改善靶区覆盖和危及器官保护的剂量学。
研究设计与样本
- 多中心回顾性队列研究,纳入2个中心2023年1月至2024年6月期间接受5次分割SBRT的74例前列腺癌患者。
- 收集自适应过程时间戳、每日勾画体积以及计划与自适应计划的DVH数据进行比较分析。
主要发现
- 95%的分次选择了自适应计划,81%的患者全部5次分次均进行了自适应。
- 平均自适应计划时间为18.7±4.8分钟(均值±标准差)。
- 预处理验证图像各主方向平均偏移<2 mm,且与自适应计划时间相关。
- 90%和68%的分次中,每日勾画的临床靶区体积分别与CT模拟勾画体积相差在5 cc和5%以内。
- 自适应计划最常见的两项DVH改善为PTV V100%和直肠V15 Gy,分别有52%和37%的分次出现至少5%的变化;85%的分次至少有一项DVH指标获得临床意义改善。
关键数值与推荐
- 自适应计划选择率95%,全部5次分次均自适应的患者占81%。
- 平均自适应计划时间18.7±4.8分钟,各主方向平均偏移<2 mm。
- PTV V100%和直肠V15 Gy分别在52%和37%的分次中出现至少5%的变化。
- 85%的分次至少有一项DVH指标获得临床意义改善。
临床怎么用
- 前列腺癌SBRT中可常规开展CTgART,在可接受的时间范围内实现靶区覆盖和危及器官保护的剂量学改善。
- 每日勾画体积与模拟CT勾画体积的差异多在5 cc和5%以内,支持在线自适应流程的可行性。
- 体重指数、治疗精囊长度及首次分次DVH改善指标数量与后续分次DVH改善数量相关,可用于预判自适应获益。
局限性
- 回顾性研究设计,仅纳入2个中心74例患者,样本量有限。
- 未报告长期临床结局、毒性或生化控制等疗效数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although computed tomography-guided online adaptive radiation therapy (CTgART) is an emerging treatment modality for prostate stereotactic body radiation therapy (SBRT), the feasibility and dosimetric improvements have not yet been quantified in a large multicenter cohort. METHODS AND MATERIALS: A cohort of 74 patients with prostate cancer treated with a 5-fraction SBRT course of CTgART between January 2023 and June 2024 was collected from 2 centers and analyzed retrospectively. Timestamps of the adaptive process and the daily contoured volumes were collected, along with dose-volume histogram (DVH) data for both the scheduled and adapted plans. The duration of the adaptive process and pretreatment verification imaging shift magnitudes were compared. Differences in DVH metrics between the scheduled and adapted plans were analyzed. RESULTS: The adapted plan was chosen in 95% of all fractions, with 81% of patients having all 5 fractions adapted. The mean adaptive planning time was 18.7 ± 4.8 minutes (mean ± standard deviation). The mean shift in each cardinal direction was <2 mm on the pretreatment verification image and was correlated with the adaptive planning time. For 90% and 68% of all fractions, the daily contoured clinical target volume was within 5 cc and 5% of the volume drawn at computed tomography simulation, respectively. The 2 most common DVH improvements on the adapted plan were the planning target volume V100% and the rectum V15 Gy, with 52% and 37% of fractions exhibiting at least a 5% change, respectively. Overall, 85% of all fractions showed at least 1 clinically meaningful improvement in a DVH metric with adaptation. Body mass index, treated seminal vesicle length, and the number of DVH metrics improved on the first fraction were correlated with the number of DVH metric improvements during subsequent fractions. CONCLUSIONS: CTgART for SBRT treatment of prostate cancer can be performed in a timely and reproducible manner while substantially improving the dosimetry of target coverage and organ-at-risk sparing.
引用
- McClatchy DM, Pursley J, Esposito C, et al. Cone Beam CT-Guided Online Adaptive Radiation Therapy for Prostate Stereotactic Body Radiation Therapy. Pract Radiat Oncol. 2026. PMID: 42431369. doi:10.1016/j.prro.2026.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。